Pharmaceuticals underperformed the S&P 500 in 2023 but have been outperforming the broader market in 2024. The PPH fund offers exposure to pharmaceutical stocks and has outperformed its peers in terms ...
VanEck Pharmaceutical ETF offers focused exposure to large-cap pharmaceutical companies, benefiting from strong long-term demographic and innovation trends. PPH's high concentration in top holdings ...
Organon, a global healthcare company dedicated to advancing women’s health, remains steadfast in its mission to create a healthier every day for every woman. Recognizing the foundational role of women ...
The Pharmaceutical ETF (PPH) is seeing unusually high volume in afternoon trading Monday, with over 232,000 shares traded versus three month average volume of about 47,000. Shares of PPH were down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback